In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-<i>d</i>]pyridazinone as Promising Cyclooxygenase Inhibitors
Since long-term use of classic NSAIDs can cause severe side effects related mainly to the gastroduodenal tract, discovery of novel cyclooxygenase inhibitors with a safe gastric profile still remains a crucial challenge. Based on the most recent literature data and previous own studies, we decided to...
Main Authors: | Krzysztof Peregrym, Łukasz Szczukowski, Benita Wiatrak, Katarzyna Potyrak, Żaneta Czyżnikowska, Piotr Świątek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/17/9130 |
Similar Items
-
Design, Synthesis and Comprehensive Investigations of Pyrrolo[3,4-<i>d</i>]Pyridazinone-Based 1,3,4-Oxadiazole as New Class of Selective COX-2 Inhibitors
by: Łukasz Szczukowski, et al.
Published: (2020-12-01) -
Novel 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-<i>d</i>]pyridazinone Exert Antinociceptive Activity in the Tail-Flick and Formalin Test in Rodents and Reveal Reduced Gastrotoxicity
by: Marta Szandruk-Bender, et al.
Published: (2020-12-01) -
Effect of Novel Pyrrolo[3,4-<i>d</i>]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation
by: Karolina Wakulik, et al.
Published: (2020-04-01) -
New 1,3,4-Oxadiazole Derivatives of Pyridothiazine-1,1-Dioxide with Anti-Inflammatory Activity
by: Teresa Glomb, et al.
Published: (2020-11-01) -
4-Chloro-5-(dimethylamino)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]pyridazin-3(2H)-one
by: Jiang, X., et al.
Published: (2022)